Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03663166
Brief Title: Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)

First Submitted : September 6, 2018
First Submitted that Met QC Criteria : September 6, 2018
First Posted : September 10, 2018

Last Update Submitted that Met QC Criteria : November 16, 2021
Last Update Posted : November 17, 2021